Multi-disciplinary management of locally advanced pancreatic cancer with irreversible electroporation.
Robert C G MartinPublished in: Journal of surgical oncology (2017)
The essential diagnosis for LAPC is based on high-quality cross-sectional imaging, which demonstrates tumor invasion into the celiac/superior mesenteric arteries and/or superior mesenteric/portal venous system that is not reconstructable. The optimal management of these patients is evolving quickly with the advent of newer chemotherapeutics, radiation, and non-thermal ablation modalities. This review will present the current status of initial chemotherapy, surgical therapy, ablative therapy, and radiation therapy for patients with nonmetastatic locally advanced unresectable pancreatic cancer.
Keyphrases
- locally advanced
- rectal cancer
- neoadjuvant chemotherapy
- squamous cell carcinoma
- radiation therapy
- phase ii study
- end stage renal disease
- cross sectional
- current status
- newly diagnosed
- ejection fraction
- chronic kidney disease
- high resolution
- peritoneal dialysis
- prognostic factors
- clinical trial
- bone marrow
- cell migration
- radiofrequency ablation
- liver metastases